Adicet Bio, Inc.
ACET · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $22,853 | $28,424 | $22,814 | $23,273 |
| G&A Expenses | $5,099 | $3,968 | $7,071 | $7,470 |
| SG&A Expenses | $5,099 | $3,968 | $7,071 | $7,470 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $27,952 | $32,392 | $29,885 | $30,743 |
| Operating Income | -$27,952 | -$32,392 | -$29,885 | -$30,743 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,096 | $1,175 | $1,671 | $2,016 |
| Pre-Tax Income | -$26,856 | -$31,217 | -$28,214 | -$28,727 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$26,856 | -$31,217 | -$28,214 | -$28,727 |
| % Margin | – | – | – | – |
| EPS | -0.29 | -0.34 | -0.31 | -0.32 |
| % Growth | 14.7% | -9.7% | 3.1% | – |
| EPS Diluted | -0.29 | -0.34 | -0.31 | -0.32 |
| Weighted Avg Shares Out | 91,086 | 91,086 | 91,071 | 87,866 |
| Weighted Avg Shares Out Dil | 91,086 | 91,086 | 91,071 | 87,866 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,172 | $1,398 | $1,683 | $2,067 |
| Interest Expense | $12 | $0 | $0 | $1 |
| Depreciation & Amortization | $1,573 | $1,655 | $1,680 | $1,623 |
| EBITDA | -$25,271 | -$29,562 | -$26,534 | -$27,103 |
| % Margin | – | – | – | – |